231 related articles for article (PubMed ID: 33309270)
1. Controversies in Testosterone Therapy.
Twitchell DK; Pastuszak AW; Khera M
Sex Med Rev; 2021 Jan; 9(1):149-159. PubMed ID: 33309270
[TBL] [Abstract][Full Text] [Related]
2. Controversies with testosterone therapy.
Khera M
Can J Urol; 2020 Aug; 27(S3):20-23. PubMed ID: 32875998
[TBL] [Abstract][Full Text] [Related]
3. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
Lundy SD; Parekh NV; Shoskes DA
J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
[TBL] [Abstract][Full Text] [Related]
4. Erythrocytosis Following Testosterone Therapy.
Ohlander SJ; Varghese B; Pastuszak AW
Sex Med Rev; 2018 Jan; 6(1):77-85. PubMed ID: 28526632
[TBL] [Abstract][Full Text] [Related]
5. The Role of Testosterone Therapy in the Setting of Prostate Cancer.
Rodriguez KM; Pastuszak AW; Khera M
Curr Urol Rep; 2018 Jun; 19(8):67. PubMed ID: 29961247
[TBL] [Abstract][Full Text] [Related]
6. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk.
Khera M; Miner M; Jaffe J; Pastuszak AW
J Sex Med; 2021 Jan; 18(1):83-98. PubMed ID: 33317996
[TBL] [Abstract][Full Text] [Related]
7. Alternatives to Testosterone Therapy: A Review.
Lo EM; Rodriguez KM; Pastuszak AW; Khera M
Sex Med Rev; 2018 Jan; 6(1):106-113. PubMed ID: 29174957
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.
Fallara G; Pozzi E; Belladelli F; Corsini C; Boeri L; Capogrosso P; Montorsi F; Salonia A
J Sex Med; 2022 Aug; 19(8):1243-1254. PubMed ID: 35753891
[TBL] [Abstract][Full Text] [Related]
9. Testosterone Therapy After Prostate Cancer Treatment: A Review of Literature.
Natale C; Carlos C; Hong J; Khera M; Baum N; Raheem OA
Sex Med Rev; 2021 Jul; 9(3):393-405. PubMed ID: 33516741
[TBL] [Abstract][Full Text] [Related]
10. Testosterone therapy in prostate cancer: is it still a controversy?
Bart AS; Van Hoof A; Badre-Hume R; Selvarajah J; Robillard K; Albala DM
Curr Opin Urol; 2022 Nov; 32(6):598-606. PubMed ID: 36081393
[TBL] [Abstract][Full Text] [Related]
11. Is testosterone a friend or a foe of the prostate?
Jannini EA; Gravina GL; Morgentaler A; Morales A; Incrocci L; Hellstrom WJ
J Sex Med; 2011 Apr; 8(4):946-55. PubMed ID: 21457469
[TBL] [Abstract][Full Text] [Related]
12. Obstructive Sleep Apnea and Testosterone Therapy.
Payne K; Lipshultz LI; Hotaling JM; Pastuszak AW
Sex Med Rev; 2021 Apr; 9(2):296-303. PubMed ID: 32636155
[TBL] [Abstract][Full Text] [Related]
13. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality.
Saad F; Caliber M; Doros G; Haider KS; Haider A
Aging Male; 2020 Mar; 23(1):81-92. PubMed ID: 30782054
[No Abstract] [Full Text] [Related]
15. Trends in Testosterone Therapy use in Prostate Cancer Survivors in the United States.
Chen T; Li S; Eisenberg ML
J Sex Med; 2021 Aug; 18(8):1346-1353. PubMed ID: 34303630
[TBL] [Abstract][Full Text] [Related]
16. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.
Sigalos JT; Pastuszak AW; Khera M
Med Clin North Am; 2018 Mar; 102(2):361-372. PubMed ID: 29406064
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine.
Morgentaler A; Traish A; Hackett G; Jones TH; Ramasamy R
Sex Med Rev; 2019 Oct; 7(4):636-649. PubMed ID: 31351915
[TBL] [Abstract][Full Text] [Related]
18. Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size.
Yassin A; Alwani M; Al-Zoubi RM; Aboumarzouk OM; Talib R; Nettleship J; Kelly D; Albaba B
Int Urol Nephrol; 2023 Jul; 55(7):1649-1658. PubMed ID: 37148486
[TBL] [Abstract][Full Text] [Related]
19. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
Haider A; Yassin A; Haider KS; Doros G; Saad F; Rosano GM
Vasc Health Risk Manag; 2016; 12():251-61. PubMed ID: 27366080
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
Hackett G
Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]